John Scowley
Family Medicine · Richmond, MONPI 1487623245
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,093 and has fallen 99.4% since, to $12 in 2021.
Across 258 payments — averaging $11.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$415
- Pfizer$334
- AstraZeneca$245
- Boehringer Ingelheim$222
- Sunovion Pharmaceuticals Inc.$177
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$175
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,973100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 36 | $415 |
| Pfizer | 32 | $334 |
| AstraZeneca | 15 | $245 |
| Boehringer Ingelheim | 22 | $222 |
| Sunovion Pharmaceuticals Inc. | 26 | $177 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $175 |
| Novartis | 12 | $161 |
| Sanofi-aventis U.S. LLC | 14 | $146 |
| Amgen(2 entities) | 14 | $138 |
| Philips North America LLC | 13 | $122 |
| Johnson & Johnson | 7 | $101 |
| Novo Nordisk | 6 | $81 |
| Merck | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $75 |
| AbbVie(2 entities) | 5 | $75 |
| Astellas Pharma US Inc | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 4 | $51 |
| Scilex Pharmaceuticals Inc. | 3 | $49 |
| GSK | 4 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Mylan Specialty L.p. | 2 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Circassia Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $16 |
| Lupin Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$2,973 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Richmond
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.